ADXN (Addex Therapeutics) Days Sales Outstanding : 871.87 (As of Sep. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Addex Therapeutics Days Sales Outstanding?

Addex Therapeutics's average Accounts Receivable for the three months ended in Sep. 2024 was $0.61 Mil. Addex Therapeutics's Revenue for the three months ended in Sep. 2024 was $0.06 Mil. Hence, Addex Therapeutics's Days Sales Outstanding for the three months ended in Sep. 2024 was 871.87.

The historical rank and industry rank for Addex Therapeutics's Days Sales Outstanding or its related term are showing as below:

ADXN' s Days Sales Outstanding Range Over the Past 10 Years
Min: 9.4 Med: 21.63 Max: 194.14
Current: 194.14

During the past 13 years, Addex Therapeutics's highest Days Sales Outstanding was 194.14. The lowest was 9.40. And the median was 21.63.

ADXN's Days Sales Outstanding is ranked worse than
86.78% of 847 companies
in the Biotechnology industry
Industry Median: 72.4 vs ADXN: 194.14

Addex Therapeutics's Days Sales Outstanding increased from Sep. 2023 (61.13) to Sep. 2024 (871.87).

Warning Sign:

If a company's sales outstanding increases, it means it has difficulty collecting payments from its customers.

Addex Therapeutics Days Sales Outstanding Historical Data

The historical data trend for Addex Therapeutics's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Addex Therapeutics Days Sales Outstanding Chart

Addex Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

25.64

8.84

14.76

74.99

56.27

Addex Therapeutics Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Days Sales Outstanding	Get a 7-Day Free Trial															61.13	85.58	44.93	278.35	871.87

Competitive Comparison of Addex Therapeutics's Days Sales Outstanding

For the Biotechnology subindustry, Addex Therapeutics's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Addex Therapeutics's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Addex Therapeutics's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Addex Therapeutics's Days Sales Outstanding falls into.

Save Embed

;

Save Embed

;

Addex Therapeutics Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Addex Therapeutics's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (0.448	+	0.127)	/	2 )	/	1.865	*	365
=	0.2875					/	1.865	*	365
=	56.27

Addex Therapeutics's Days Sales Outstanding for the quarter that ended in Sep. 2024 is calculated as:

	Days Sales Outstanding (Q: Sep. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2024 )	+	Accounts Receivable (A: Sep. 2024 ))	/	count )	/	Revenue (A: Sep. 2024 )	*	Days in Period
=	( (0.656	+	0.567)	/	2 )	/	0.064	*	365 / 4
=	0.6115					/	0.064	*	365 / 4
=	871.87

Addex Therapeutics (NAS:ADXN) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Addex Therapeutics Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Addex Therapeutics's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Addex Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Addex Therapeutics Ltd (NAS:ADXN) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

ADXNz:UK APE1:Germany ADXN:Switzerland

Address

Chemin des Mines 9, Geneva, CHE, 1202

Website

https://www.addextherapeutics.com

Addex Therapeutics Ltd is a clinical stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment which is the discovery, development and commercialization of small-molecule pharmaceutical products.